ANIXA BIOSCIENCES, INC. Stock-Based Compensation
ANIXA BIOSCIENCES, INC. (ANIX) reported Stock-Based Compensation of $2.04 million for the 9-month period ending 2026-07-31, per its 10-Q filed 2026-09-09.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-09-09
- ANIXA BIOSCIENCES, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-07-31 was $637.00K, a 23.16% decline year-over-year.
- ANIXA BIOSCIENCES, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-04-30 was $637.00K, a 33.78% decline year-over-year.
- ANIXA BIOSCIENCES, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-01-31 was $768.00K, a 25.51% decline year-over-year.
- ANIXA BIOSCIENCES, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-10-31 was $859.00K, a 12.35% decline year-over-year.
- ANIXA BIOSCIENCES, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $3.68M, a 16.72% decline from fiscal 2024.
- ANIXA BIOSCIENCES, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $4.42M, a 0.05% decline from fiscal 2023.
- ANIXA BIOSCIENCES, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $4.42M, a 26.30% decline from fiscal 2022.
- ANIXA BIOSCIENCES, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $6.00M, a 20.03% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-07-31 | $637.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-09-09 | $1.27M derived: sum of 2 quarters · filed 2026-09-09 | $2.04M 10-Q · filed 2026-09-09 | $2.90M derived: sum of 4 quarters · filed 2026-09-09 | ||
| 2026-04-30 | $637.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-06-10 | $1.41M 10-Q · filed 2026-06-10 | $2.26M derived: sum of 3 quarters · filed 2026-06-10 | $3.09M derived: sum of 4 quarters · filed 2026-09-09 | ||
| 2026-01-31 | $768.00K 10-Q · filed 2026-03-09 | $1.63M derived: sum of 2 quarters · filed 2026-03-09 | $2.46M derived: sum of 3 quarters · filed 2026-09-09 | $3.42M derived: sum of 4 quarters · filed 2026-09-09 | ||
| 2025-10-31 | $859.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-12 | $1.69M derived: sum of 2 quarters · filed 2026-09-09 | $2.65M derived: sum of 3 quarters · filed 2026-09-09 | $3.68M 10-K · filed 2026-01-12 | ||
| 2025-07-31 | $829.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-09-09 | $1.79M derived: sum of 2 quarters · filed 2026-09-09 | $2.82M 10-Q · filed 2026-09-09 | $3.80M derived: sum of 4 quarters · filed 2026-09-09 | ||
| 2025-04-30 | $962.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-06-10 | $1.99M 10-Q · filed 2026-06-10 | $2.97M derived: sum of 3 quarters · filed 2026-06-10 | $4.07M derived: sum of 4 quarters · filed 2026-06-10 | ||
| 2025-01-31 | $1.03M 10-Q · filed 2026-03-09 | $2.01M derived: sum of 2 quarters · filed 2026-03-09 | $3.10M derived: sum of 3 quarters · filed 2026-03-09 | $4.34M derived: sum of 4 quarters · filed 2026-03-09 | ||
| 2024-10-31 | $980.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-12 | $2.07M derived: sum of 2 quarters · filed 2026-01-12 | $3.31M derived: sum of 3 quarters · filed 2026-01-12 | $4.42M 10-K · filed 2026-01-12 | ||
| 2024-07-31 | $1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-09-10 | $2.33M derived: sum of 2 quarters · filed 2025-09-10 | $3.44M 10-Q · filed 2025-09-10 | $4.60M derived: sum of 4 quarters · filed 2025-09-10 | ||
| 2024-04-30 | $1.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-28 | $2.35M 10-Q · filed 2025-05-28 | $3.50M derived: sum of 3 quarters · filed 2025-05-28 | $4.66M derived: sum of 4 quarters · filed 2025-05-28 | ||
| 2024-01-31 | $1.11M 10-Q · filed 2025-03-11 | $2.27M derived: sum of 2 quarters · filed 2025-03-11 | $3.42M derived: sum of 3 quarters · filed 2025-03-11 | $4.57M derived: sum of 4 quarters · filed 2025-03-11 | ||
| 2023-10-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-10 | $2.31M derived: sum of 2 quarters · filed 2025-01-10 | $3.46M derived: sum of 3 quarters · filed 2025-01-10 | $4.42M 10-K · filed 2025-01-10 | ||
| 2023-07-31 | $1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-09-06 | $2.31M derived: sum of 2 quarters · filed 2024-09-06 | $3.27M 10-Q · filed 2024-09-06 | $4.34M derived: sum of 4 quarters · filed 2024-09-06 | ||
| 2023-04-30 | $1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-06-04 | $2.11M 10-Q · filed 2024-06-04 | $3.18M derived: sum of 3 quarters · filed 2024-06-04 | $4.51M derived: sum of 4 quarters · filed 2024-06-04 | ||
| 2023-01-31 | $957.00K 10-Q · filed 2024-03-12 | $2.03M derived: sum of 2 quarters · filed 2024-03-12 | $3.36M derived: sum of 3 quarters · filed 2024-03-12 | $4.82M derived: sum of 4 quarters · filed 2024-03-12 | ||
| 2022-10-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-16 | $2.40M derived: sum of 2 quarters · filed 2024-01-16 | $3.87M derived: sum of 3 quarters · filed 2024-01-16 | $6.00M 10-K · filed 2024-01-16 | ||
| 2022-07-31 | $1.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-09-06 | $2.79M derived: sum of 2 quarters · filed 2023-09-06 | $4.93M 10-Q · filed 2023-09-06 | $7.63M derived: sum of 4 quarters · filed 2023-09-06 | ||
| 2022-04-30 | $1.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-06-14 | $3.60M 10-Q · filed 2023-06-14 | $6.30M derived: sum of 3 quarters · filed 2023-06-14 | $9.35M derived: sum of 4 quarters · filed 2023-06-14 | ||
| 2022-01-31 | $2.13M 10-Q · filed 2023-03-17 | $4.83M derived: sum of 2 quarters · filed 2023-03-17 | $7.88M derived: sum of 3 quarters · filed 2023-03-17 | $8.76M derived: sum of 4 quarters · filed 2023-03-17 | ||
| 2021-10-31 | $2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-04 | $5.75M derived: sum of 2 quarters · filed 2023-01-04 | $6.63M derived: sum of 3 quarters · filed 2023-01-04 | $7.50M 10-K · filed 2023-01-04 | $7.50M 10-K · filed 2022-01-04 | |
| 2021-07-31 | $3.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-09-09 | $3.93M derived: sum of 2 quarters · filed 2022-09-09 | $4.80M 10-Q · filed 2022-09-09 | $8.73M derived: sum of 4 quarters · filed 2022-09-09 | ||
| 2021-04-30 | $881.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-06-10 | $1.76M 10-Q · filed 2022-06-10 | $5.68M derived: sum of 3 quarters · filed 2022-06-10 | |||
| 2021-01-31 | $875.00K 10-Q · filed 2022-03-11 | $4.80M derived: sum of 2 quarters · filed 2022-03-11 | ||||
| 2020-10-31 | $3.92M derived: 10-K 12 month − 10-Q 9 month · filed 2022-01-04 | $3.92M 10-K · filed 2022-01-04 | ||||
| 2020-07-31 | $0.00 10-Q · filed 2020-09-08 | |||||
| 2019-07-31 | $376.00K 10-Q · filed 2020-09-08 | |||||
| 2016-07-31 | $240.00K 10-Q · filed 2016-08-19 | |||||
| 2015-07-31 | $445.00K 10-Q · filed 2016-08-19 | |||||
| 2015-02-05 | $297.00K 10-Q · filed 2015-05-22 | |||||
| 2014-10-31 | $565.37K derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-29 | $1.14M derived: sum of 2 quarters · filed 2015-01-29 | $1.66M derived: sum of 3 quarters · filed 2015-01-29 | $2.13M 10-K · filed 2015-01-29 | ||
| 2014-07-31 | $572.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-09-15 | $1.10M derived: sum of 2 quarters · filed 2014-09-15 | $1.56M 10-Q · filed 2014-09-15 | $2.14M derived: sum of 4 quarters · filed 2015-01-29 | ||
| 2014-04-30 | $523.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-16 | $989.41K 10-Q · filed 2014-06-16 | $1.56M derived: sum of 3 quarters · filed 2015-01-29 | $2.65M derived: sum of 4 quarters · filed 2015-01-29 | ||
| 2014-01-31 | $465.52K 10-Q · filed 2014-03-17 | $1.04M derived: sum of 2 quarters · filed 2015-01-29 | $2.13M derived: sum of 3 quarters · filed 2015-01-29 | $2.69M derived: sum of 4 quarters · filed 2015-01-29 | ||
| 2013-10-31 | $574.70K derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-29 | $1.67M derived: sum of 2 quarters · filed 2015-01-29 | $2.22M derived: sum of 3 quarters · filed 2015-01-29 | $2.69M 10-K · filed 2015-01-29 | ||
| 2013-07-31 | $1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-09-15 | $1.65M derived: sum of 2 quarters · filed 2014-09-15 | $2.12M 10-Q · filed 2014-09-15 | |||
| 2013-04-30 | $554.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-16 | $1.03M 10-Q · filed 2014-06-16 | ||||
| 2013-01-31 | $473.27K 10-Q · filed 2014-03-17 | |||||
| 2012-10-31 | $927.00K 10-K · filed 2013-01-29 | |||||
| 2011-10-31 | $1.82M 10-K · filed 2013-01-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |